Apple partners with brain-computer interface startup Synchron to explore letting iPhone users control the device using brain signals via a stent-like implant
iPhone-maker works with startup Synchron on new brain computer interfaces to help disabled people use its devices
Context & Ripple Effects
Apple has been extending device access beyond touch: its 2024 accessibility rollout included Eye Tracking controls for iPhone and iPad. The Synchron collaboration moves that work toward an implant-mediated input path for people with severe mobility limitations.
Synchron had already demonstrated its implant being used with iPhones and voice assistants by people with paralysis, following its earlier work on a blood-vessel-delivered brain-interface approach. Apple’s involvement matters because it connects that emerging capability to a major device platform.
First-order effects
- Apple and Synchron can evaluate how brain-signal input could work with iPhone accessibility and device controls for disabled users.
- Synchron gains a direct partnership with the iPhone maker, while Apple broadens its accessibility-interface exploration beyond eye-based control.
Second-order effects
- Brain-computer-interface developers will have a stronger incentive to make their systems compatible with mainstream mobile platforms rather than treating device control as a standalone demonstration.
- Other device platforms may face added pressure to show how their accessibility frameworks can accommodate new forms of non-touch input if Apple and Synchron produce usable integrations.
Third-order effects
- If such integrations progress beyond exploration, accessibility could become a more important route by which implant makers reach everyday consumer computing, tying clinical hardware more closely to platform software.
- The broader shift is from a single default interface—touch—to layered, user-specific input methods, although real adoption will depend on whether these systems prove practical for the intended users.
The trend: Consumer-device accessibility is expanding from adaptive software features toward compatibility with specialized biological and assistive input hardware.